Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligoprogression”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06882499
What this trial is testing

Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II

Who this might be right for
Breast Cancer, MetastaticMetastatic Breast Cancer
Peter MacCallum Cancer Centre, Australia 74
Testing effectiveness (Phase 2)Looking for participantsNCT04989725
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer

Who this might be right for
Metastatic CancerOligoprogressive
Centre hospitalier de l'Université de Montréal (CHUM) 46
Not applicableActive Not RecruitingNCT04624828
What this trial is testing

Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT

Who this might be right for
Oligorecurrent and Oligoprogressive Prostate Cancer Patients
Istituto Clinico Humanitas 40
Testing effectiveness (Phase 2)Looking for participantsNCT06260033
What this trial is testing

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor-Positive Breast CarcinomaMetastatic Breast Carcinoma
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05089916
What this trial is testing

Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study

Who this might be right for
NSCLCEGFR Positive Non-small Cell Lung CancerOligoprogression
AIO-Studien-gGmbH 42
Testing effectiveness (Phase 2)Looking for participantsNCT07038304
What this trial is testing

The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer (Adenocarcinoma)OligoProgressive Metastatic DiseaseCastration Resistant Metastatic Prostate Cancer+1 more
University Medical Center Groningen 35
Large-scale testing (Phase 3)Looking for participantsNCT06523673
What this trial is testing

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung CancerNSCLC Stage IVOligoProgressive Metastatic Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine 104
Not applicableNot Yet RecruitingNCT06489821
What this trial is testing

STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer

Who this might be right for
Metastatic Breast CancerOligoprogression
Juravinski Cancer Center 36
Large-scale testing (Phase 3)Looking for participantsNCT06841172
What this trial is testing

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

Who this might be right for
OligoProgressive Metastatic DiseaseHepatocellular Carcinoma (HCC)Radiotherapy+1 more
Shandong Cancer Hospital and Institute 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT04405401
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

Who this might be right for
Lung Cancer Metastatic
Centre hospitalier de l'Université de Montréal (CHUM) 68
Testing effectiveness (Phase 2)WithdrawnNCT06331585
What this trial is testing

Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy

Who this might be right for
Low-dose RadiotherapyTumor MicroenvironmentNon-Small Cell Lung Cancer
Hetian District People's Hospital
Large-scale testing (Phase 3)Looking for participantsNCT06367972
What this trial is testing

Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

Who this might be right for
OligoProgressive Metastatic Disease
M.D. Anderson Cancer Center 400
Not applicableLooking for participantsNCT06925984
What this trial is testing

Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)

Who this might be right for
OligoProgressive Metastatic Disease
Jules Bordet Institute 48
Testing effectiveness (Phase 2)Looking for participantsNCT04299646
What this trial is testing

A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

Who this might be right for
Metastatic Renal Cell CarcinomaRadiotherapy
Centre Francois Baclesse 77
Not applicableLooking for participantsNCT06101277
What this trial is testing

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Who this might be right for
Small Bowel CancerColorectal CancerAppendiceal Cancer+5 more
University of California, Davis 300
Not applicableActive Not RecruitingNCT06055881
What this trial is testing

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy

Who this might be right for
Breast CarcinomaAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Cancer
Mayo Clinic 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07781202
What this trial is testing

A Multicenter, Single-Arm, Prospective Phase II Clinical Study of Trastuzumab Rezetecan Combined With Radiotherapy in Patients With HER2-Mutated Oligoprogressive Advanced Non-Small Cell Lung Cancer

Who this might be right for
HER2-mutated Advanced Non-small Cell Lung Cancer With Oligoprogression
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Ended earlyNCT04549428
What this trial is testing

Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC

Who this might be right for
NSCLC Stage IV
Oncology Institute of Southern Switzerland 12
Testing effectiveness (Phase 2)WithdrawnNCT04485026
What this trial is testing

Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma

Who this might be right for
Non Small Cell Lung CancerOligoprogressive
Wake Forest University Health Sciences
Not applicableLooking for participantsNCT05784428
What this trial is testing

Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

Who this might be right for
Oligometastatic DiseaseOligoprogressionToxicity Due to Radiotherapy+1 more
Robert Olson 598
Next Page